Related Experiment Video
Updated: Jun 23, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure
B Andersson1, K Caidahl, F Waagstein
1Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Sjukhuset, Goteborg University, Sweden.
Insights
Idiopathic dilated cardiomyopathy (IDCM) affects 29.2 per million people annually, with incidence rising with age. This study determined the true incidence and prevalence of IDCM in a defined population.
Area of Science:
- Cardiology
- Epidemiology
Background:
- Idiopathic dilated cardiomyopathy (IDCM) is a diagnosis of exclusion with significant prognostic implications.
- The current incidence and age distribution of IDCM in a well-defined population remain largely unknown.
- Understanding IDCM epidemiology is crucial for resource allocation and treatment strategies.
Purpose of the Study:
- To estimate the proportion of IDCM among congestive heart failure (CHF) patients.
- To determine the age- and gender-standardized incidence rate of IDCM.
- To evaluate the prognostic implications and prevalence of IDCM in a defined region.
Main Methods:
- Retrospective analysis of 2711 patient records (16-65 years) hospitalized for CHF or IDCM over 6 years in Western Sweden.
- Diagnostic investigation including echocardiography for 411 patients lacking an obvious etiology for CHF/IDCM.
- Comparison of affected patients with a control group of 103 healthy individuals.
Main Results:
- 27% of living CHF patients lacked an identifiable cause; 30% of these showed left ventricular dilatation and systolic dysfunction.
- An age-gender standardized incidence rate of 29.2 cases per 10^6 persons/year for IDCM was established.
- IDCM incidence increased with age and was higher in urban than rural areas (32 vs 21/10^6).
Conclusions:
- The study provides crucial epidemiological data on IDCM incidence and prevalence.
- IDCM's relative contribution to heart failure is greater in younger individuals.
- Findings highlight the need for continued research into IDCM etiology and management.
Abstract:
Idiopathic dilated cardiomyopathy (IDCM) is an exclusion diagnosis. Although it is a prognostically important entity and a common indication for cardiac transplantation, the incidence and age distribution of idiopathic IDCM in a well-defined population today is unknown. The present study intended to estimate the proportion of IDCM among congestive heart failure (CHF) patients, and to evaluate its prognostic implications. The records of all 16-65-year-old patients hospitalized for CHF or IDCM during a 6-year period (n = 2711) were evaluated in a defined region of Western Sweden (1.05 million inhabitants 16-65 years of age). Twenty-two percent (584/2711) of these records contained no plausible cause of CHF or IDCM, and among living patients an obvious aetiology was lacking in 27% (411/1516). These 411 patients were subsequently offered a diagnostic investigation including echocardiography, and were compared to a randomly selected healthy control group (n = 103). Of 411 patients, 293 accepted the investigation and 286 had acceptable echocardiographic recordings, indicating left ventricular dilatation and systolic dysfunction in 30%. From the hospital records, 170 patients were identified as new cases of IDCM during the 6-year period. Adding another 34 cases revealed by our diagnostic procedures yielded an age-gender standardized incidence rate of 29.2 cases per 10(6) persons/year. The incidence of IDCM increased considerably with age, although in younger patients its relative contribution to heart failure was greater. The incidence of IDCM was higher in the urban compared to the rural parts of the region 21 vs 32/10(6); P = 0.013). The estimated prevalence was 131/10(6).(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

